PharmaNet Development Group has joined Medidata’s “ASPire to Win” channel partner program, and will add the SaaS company’s electronic data capture (EDC) and clinical data management (CDM) solution for use in its conduct of global clinical trials.

PharmaNet joined this CRO partner program to facilitate the use of Medidata Rave for a range of Phase I–IV clinical studies, including large, complex global studies, taking advantage of Rave’s interface for clinical investigators that facilitates site recruitment and retention. Rave’s extensive data management and reporting capabilities are designed to support the research sponsor in driving efficiencies throughout the clinical development process, according to a Medidata statement.

“Our clients consistently challenge us to provide the highest-quality services while running their trials efficiently — Rave helps us achieve those goals,” said Dalvir Gill, Ph.D., president, Late Stage Development, PharmaNet. “It provides the scalability to support our global footprint and the flexibility we need to create eClinical environments for rapid data sharing. From its ease-of-use and multilingual support to its double data entry and robust reporting for effective data analysis – Rave will effectively support the diverse group of investigators who participate in our studies.”

PharmaNet has more than ten years of experience conducting EDC trials utilizing both commercially available EDC systems and its proprietary ones. Medidata’s channel partner program began in April 2005 and includes more than 25 CRO partners.